Cargando…
Investigating cellular identity and manipulating cell fate using induced pluripotent stem cells
Induced pluripotent stem (iPS) cells, obtained from reprogramming somatic cells by ectopic expression of a defined set of transcription factors or chemicals, are expected to be used as differentiated cells for drug screening or evaluations of drug toxicity and cell replacement therapies. As pluripot...
Autores principales: | Sugawara, Tohru, Nishino, Koichiro, Umezawa, Akihiro, Akutsu, Hidenori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392777/ https://www.ncbi.nlm.nih.gov/pubmed/22405125 http://dx.doi.org/10.1186/scrt99 |
Ejemplares similares
-
A single allele of the hsa-miR-302/367 cluster maintains human pluripotent stem cells
por: Sugawara, Tohru, et al.
Publicado: (2022) -
The hsa-miR-302 cluster controls ectodermal differentiation of human pluripotent stem cell via repression of DAZAP2
por: Sugawara, Tohru, et al.
Publicado: (2020) -
Identification of an epigenetic signature in human induced pluripotent stem cells using a linear machine learning model
por: Nishino, Koichiro, et al.
Publicado: (2020) -
DNA Methylation Dynamics in Human Induced Pluripotent Stem Cells over Time
por: Nishino, Koichiro, et al.
Publicado: (2011) -
Variation of DNA methylation on the IRX1/2 genes is responsible for the neural differentiation propensity in human induced pluripotent stem cells
por: Sekiya, Asato, et al.
Publicado: (2022)